Progressions in Cardiac Arrhythmia: Specific Populations and the Need for Precision Medicine

por Rivera-Caravaca, José Miguel, Hendriks, Jeroen M.
Publicado 2023

Editorial: New horizons in the management of patients with atrial fibrillation: Interactions with the gastrointestinal system

por Rivera-Caravaca, José Miguel, Lip, Gregory Y. H., Roldán, Vanessa, Marín, Francisco
Publicado 2022

Non-vitamin K Antagonist Oral Anticoagulants and Drug-Food Interactions: Implications for Clinical Practice and Potential Role of Probiotics and Prebiotics

por Sánchez-Fuentes, Ana, Rivera-Caravaca, José Miguel, López-Gálvez, Raquel, Marín, Francisco, Roldán, Vanessa
Publicado 2022

Incident heart failure, arrhythmias and cardiovascular outcomes with sodium‐glucose cotransporter 2 (SGLT2) inhibitor use in patients with diabetes: Insights from a global federate...

por Fawzy, Ameenathul Mazaya, Rivera‐Caravaca, José Miguel, Underhill, Paula, Fauchier, Laurent, Lip, Gregory Y. H.
Publicado 2022

Relationship between temporal rhythm-based classification of atrial fibrillation and stroke: real-world vs. clinical trial

por Ding, Wern Yew, Rivera-Caravaca, José Miguel, Marin, Francisco, Roldán, Vanessa, Lip, Gregory Y. H.
Publicado 2022

Cardiovascular risk factors, cardiovascular disease, and COVID-19: an umbrella review of systematic reviews

por Harrison, Stephanie L, Buckley, Benjamin J R, Rivera-Caravaca, José Miguel, Zhang, Juqian, Lip, Gregory Y H
Publicado 2021

The Atrial Fibrillation Better Care (ABC) Pathway and Clinical Outcomes in Patients with Atrial Fibrillation: the Prospective Murcia AF Project Phase II Cohort

por Rivera-Caravaca, José Miguel, Roldán, Vanessa, Martínez-Montesinos, Lorena, Vicente, Vicente, Lip, Gregory Y.H., Marín, Francisco
Publicado 2022

Prediction of Residual Stroke Risk in Anticoagulated Patients with Atrial Fibrillation: mCARS

por Ding, Wern Yew, Rivera-Caravaca, José Miguel, Marin, Francisco, Torp-Pedersen, Christian, Roldán, Vanessa, Lip, Gregory Y. H.
Publicado 2021

Predicting Bleeding Events in Anticoagulated Patients With Atrial Fibrillation: A Comparison Between the HAS‐BLED and GARFIELD‐AF Bleeding Scores

por Proietti, Marco, Rivera‐Caravaca, José Miguel, Esteve‐Pastor, María Asunción, Romiti, Giulio Francesco, Marin, Francísco, Lip, Gregory Y. H.
Publicado 2018

Long‐Term Stroke Risk Prediction in Patients With Atrial Fibrillation: Comparison of the ABC‐Stroke and CHA (2) DS (2)‐VASc Scores

por Rivera‐Caravaca, José Miguel, Roldán, Vanessa, Esteve‐Pastor, María Asunción, Valdés, Mariano, Vicente, Vicente, Lip, Gregory Y. H., Marín, Francisco
Publicado 2017

Importance of time in therapeutic range on bleeding risk prediction using clinical risk scores in patients with atrial fibrillation

por Rivera-Caravaca, José Miguel, Roldán, Vanessa, Esteve-Pastor, María Asunción, Valdés, Mariano, Vicente, Vicente, Lip, Gregory Y. H., Marín, Francisco
Publicado 2017

Murcia atrial fibrillation project II: protocol for a prospective observational study in patients with atrial fibrillation

por Rivera-Caravaca, José Miguel, Marín, Francisco, Esteve-Pastor, María Asunción, Gálvez, Josefa, Lip, Gregory Y.H., Vicente, Vicente, Roldán, Vanessa
Publicado 2019

Outcomes of left atrial appendage occlusion vs. non-vitamin K antagonist oral anticoagulants in atrial fibrillation

por Ding, Wern Yew, Rivera-Caravaca, José Miguel, Fazio-Eynullayeva, Elnara, Underhill, Paula, Gupta, Dhiraj, Marín, Francisco, Lip, Gregory Y. H.
Publicado 2022

Gut Microbiota and the Quality of Oral Anticoagulation in Vitamin K Antagonists Users: A Review of Potential Implications

por Camelo-Castillo, Anny, Rivera-Caravaca, José Miguel, Orenes-Piñero, Esteban, Ramírez-Macías, Inmaculada, Roldán, Vanessa, Lip, Gregory Y. H., Marín, Francisco
Publicado 2021

Relation of the ‘Atrial Fibrillation Better Care (ABC) Pathway’ to the Quality of Anticoagulation in Atrial Fibrillation Patients Taking Vitamin K Antagonists

por Roldán, Vanessa, Martínez-Montesinos, Lorena, López-Gálvez, Raquel, García-Tomás, Lucía, Lip, Gregory Y. H., Rivera-Caravaca, José Miguel, Marín, Francisco
Publicado 2022

Does von Willebrand factor improve the predictive ability of current risk stratification scores in patients with atrial fibrillation?

por García-Fernández, Amaya, Roldán, Vanessa, Rivera-Caravaca, José Miguel, Hernández-Romero, Diana, Valdés, Mariano, Vicente, Vicente, Lip, Gregory Y. H., Marín, Francisco
Publicado 2017

Direct-acting oral anticoagulants use prior to COVID-19 diagnosis and associations with 30-day clinical outcomes

por Rivera-Caravaca, José Miguel, Buckley, Benjamin J.R., Harrison, Stephanie L., Fazio-Eynullayeva, Elnara, Underhill, Paula, Marín, Francisco, Lip, Gregory Y.H.
Publicado 2021

Efficacy and safety of direct-acting oral anticoagulants compared to vitamin K antagonists in COVID-19 outpatients with cardiometabolic diseases

por Rivera-Caravaca, José Miguel, Harrison, Stephanie L., Buckley, Benjamin J. R., Fazio-Eynullayeva, Elnara, Underhill, Paula, Marín, Francisco, Lip, Gregory Y. H.
Publicado 2021

Occupational Therapy in Severe Mental Disorder—A Self-Controlled Quasi-Experimental Study

por Valverde-Bolivar, Efrén, Simonelli-Muñoz, Agustín Javier, Rivera-Caravaca, José Miguel, Gallego-Gómez, Juana Inés, Rodríguez González-Moro, María Teresa, García-Arenas, José Joaquín
Publicado 2022

Galectin-3 and β-trace protein concentrations are higher in clinically unaffected patients with Fabry disease

por Hernández-Romero, Diana, Sánchez-Quiñones, Jessica, Vílchez, Juan Antonio, Rivera-Caravaca, José Miguel, de la Morena, Gonzalo, Lip, Gregory Y. H., Climent, Vicente, Marín, Francisco
Publicado 2019